Project Description

A Message to Our Sponsors Regarding COVID-19

March 25, 2020

To our valued Sponsors and partners,

As the global public health crisis of COVID-19 unfolds, we understand it means new demands and shifting priorities for our life science clients. In these challenging times, our team at Health Decisions is fully prepared to support you as we navigate this new environment and the potential implications on your clinical studies due to restricted travel and quarantine orders that could impact all aspects of clinical research. The events are unprecedented.

Our priorities continue to be the safety and well-being of trial participants and employees, and optimizing study continuity plans for our Sponsors. We are making every effort to ensure that we continue to deliver the level of excellence that you have come to expect from us, despite the challenges that we all face. Rest assured, we have the infrastructure in place to support work on a fully remote basis for an extended period. Our entire team stands ready to assist you in any way we can.

In this regard, Health Decisions has been proactively monitoring relevant guidance from regulatory authorities regarding how to handle potential COVID-19 related study disruptions, as well as following guidance from CDC and local health authorities to ensure adherence to the recommendations being provided by those who are on the front lines of combating COVID-19.

For active projects, we have created project-specific contingency plans that our Project Managers will share so that measures to be taken can be mutually agreed upon. All site staff have been contacted so that we can fully understand the current impact of the virus at each facility and the ability to support study continuity as we move forward. Where site visits are no longer possible, we have deployed remote monitoring and other alternative solutions to allow studies to continue moving forward.

Since its founding over thirty years ago, Health Decisions has been dedicated to supporting life science organizations as they develop new and innovative treatments to improve health and healthcare in Women’s Health and Diagnostics. Now more than ever, we are committed to this mission as we all navigate through these unprecedented times.

If you have any questions or if we can provide any additional support, please do not hesitate to contact us. We are here to help. Most importantly, please take care of yourself and those around you and stay well.

Kind regards,

Dr. Patrick Phillips, BSc(Hons) D.Phil.

Chief Executive Officer, Health Decisions